Interacting with and seeking product approval from the FDA is always a hurdle for pharmaceutical, medical device, biologics and cosmetic companies. AGG’s frequent client alerts keep companies informed of the latest FDA-related developments.
We welcome your interest in AGG. However, we cannot represent you nor can we treat unsolicited information as confidential until we know that doing so will not create a conflict of interest. Accordingly, please DO NOT send information about any matter unless you have a written engagement letter from us stating that we represent you as a client.